Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival

Transplant Proc. 1996 Apr;28(2):571-2.

Authors

A R Lussow¹, L Fanget, L Gao, R Buelow, P Pouletty

Affiliation

¹ SangStat Medical Corporation, Menlo Park, California 94025, USA.

PMID: 8623277

No abstract available

MeSH terms

Animals
Antigens, Heterophile / immunology*
Carbohydrate Sequence
Cytotoxicity, Immunologic*
Disaccharides / immunology*
Graft Survival / drug effects
Graft Survival / immunology*
Haptens
Heart Transplantation / immunology*
Immunosuppression Therapy
Interleukin-2 / therapeutic use*
Lymphocyte Activation*
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Molecular Sequence Data
T-Lymphocytes / immunology*
Transplantation, Heterologous / immunology*
Transplantation, Homologous / immunology

Substances

Antigens, Heterophile
Disaccharides
Haptens
Interleukin-2
galactosyl-(1-3)galactose